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SUMMARY

Altered neuronal excitability is one of the hallmarks of
fragile X syndrome (FXS), but the mechanisms underlying this critical neuronal dysfunction are poorly
understood. Here, we find that pyramidal cells in
the entorhinal cortex of Fmr1 KO mice, an established FXS mouse model, display a decreased AP
threshold and increased neuronal excitability. The
AP threshold changes in Fmr1 KO mice are caused
by increased persistent sodium current (INaP). Our results indicate that this abnormal INaP in Fmr1 KO
animals is mediated by increased mGluR5-PLCPKC (metabotropic glutamate receptor 5/phospholipase C/protein kinase C) signaling. These findings
identify Na+ channel dysregulation as a major cause
of neuronal hyperexcitability in cortical FXS neurons
and uncover a mechanism by which abnormal
mGluR5 signaling causes neuronal hyperexcitability
in a FXS mouse model.
INTRODUCTION
Fragile X syndrome (FXS), the most common cause of inherited
intellectual disability, is typically associated with cognitive,
behavioral, and social impairments, as well as a wide range of
neurological abnormalities (Santoro et al., 2012). A prominent
characteristic of neurological defects in FXS is neuronal hyperexcitability, which is believed to cause a variety of symptoms,
including hyperactivity, increased sensitivity to sensory stimuli,
and a high incidence of seizures (Contractor et al., 2015). These
phenotypes account for a considerable part of the disease
pathophysiology. However, the underlying mechanisms responsible for increased neuronal excitability in FXS remain poorly
understood.
Altered neuronal excitability has been reported in various
brain regions of FXS models (Deng et al., 2013; Gibson et al.,
2008; Kalmbach et al., 2015; Myrick et al., 2015; Tang and
Alger, 2015; Zhang et al., 2014). Among these regions, the parahippocampal cortices—and, particularly, the entorhinal cortex
(EC)—play an essential role in the generation and maintenance

of a wide range of seizure syndromes (Chatzikonstantinou,
2014). Anatomically, EC mediates the majority of connections
between various brain regions and the hippocampus, which is
one of the most heavily investigated brain areas implicated in
the pathology of FXS (Santoro et al., 2012). Thus, the EC is
regarded as the gateway to the hippocampus and has been
implicated as one of the key epileptogenic brain areas (Chatzikonstantinou, 2014). Despite its critical role in cortico-hippocampal network excitability, little is known about pathophysiological changes in the EC that occur in FXS models. Thus, EC
represents a highly relevant model system to investigate excitability defects in FXS.
Action potential (AP) threshold is one of the key determinants
of neuronal excitability (Bean, 2007). The threshold determines
when an AP is initiated, sets the neuron’s firing rate, and shapes
neuronal computations, including coincidence detection, temporal coding, and feature selectivity (Bean, 2007). AP threshold
is governed predominately by Na+ channel availability and activation propensity near the threshold, whereas K+ channels and
other conductances can dynamically modulate AP threshold in
an adaptive way (Carter and Bean, 2009; Hu et al., 2009; Platkiewicz and Brette, 2010). In addition to the fast transient Na+ current (INaT) underlying the AP rising phase, the Na+ channels can
give rise to a noninactivating persistent Na+ current (INaP) that
activates at subthreshold voltages (Crill, 1996). Although the
amplitude of INaP is generally small, relative to the INaT, it is highly
functionally significant and may strongly influence transduction
of synaptic inputs into AP generation (Crill, 1996; Hu et al.,
2009). Here, we demonstrate that INaP is abnormally increased
in the EC layer III excitatory pyramidal neurons of Fmr1 KO
mice, leading to decreased AP threshold and increased neuronal
excitability. Our results suggest that this enhanced INaP is caused
by exaggerated metabotropic glutamate receptor 5 (mGluR5)
signaling acting via phospholipase C (PLC) and protein kinase
C (PKC), a signaling mechanism distinct from the well-established mGluR5 signaling cascade affecting local translation in
Fmr1 knockout (KO) animals. These findings identify Na+ channel
dysregulation as a major cause of neuronal hyperexcitability in
cortical FXS neurons and uncover a previously unrecognized
mechanism by which abnormal mGluR5 signaling causes neuronal hyperexcitability in an FXS mouse model. Our findings
may, thus, provide a therapeutic strategy to ameliorate neuronal
excitability defects in FXS.
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Figure 1. Increased Neuronal Excitability in
the EC Layer III PCs of Fmr1 KO Mice
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(A) Determination of AP threshold. APs were evoked
by a ramp current injection (0.1 pA/ms, lower
trace). Representative AP traces from EC layer III
PCs are shown (upper traces). Only the first AP was
used to estimate the AP threshold (box area).
(B) Enlargement of boxed area in (A) showing a
hyperpolarizing shift of threshold voltage in Fmr1
KO neuron. Arrows denote the thresholds in WT
and Fmr1 KO neurons.
(C) Decreased threshold voltage was found in the
PCs, but not the stellate cells (SCs), in the EC
superficial layers.
(D) Sample traces of spontaneous APs recorded
at 51 mV in WT and Fmr1 KO neurons.
(E) Spontaneous AP frequency distribution. A bin
size of 0.5 Hz was used to calculate AP firing frequency distribution from a 20-s-long trace per cell.
The number of APs within a bin was divided by the
total number of APs for pooling the data from all
tested cells. Insert numbers denote the peak frequency and percentile estimated from Gaussian fits.
(F) Mean AP firing frequency in Fmr1 KO and WT
EC layer III PCs, data averaged from (E).
(G) Threshold estimates for spontaneous APs.
Each point represents an averaged AP threshold
in one cell (from all APs in a 20-s-long trace in each
cell). Inset AP traces show a hyperpolarizing shift
of threshold in Fmr1 KO neurons (arrows). Bar
graph shows mean thresholds for all cells.
**p < 0.01; ns, not significant. All data are
means ± SEM.
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RESULTS
Increased Pyramidal Cell Excitability in the EC of Fmr1
KO Mice
Superficial layers (layers II–III) of the EC serve as an information
gateway to the hippocampus. Accordingly, we first asked
whether the excitability of the principal neurons in EC superficial
layers (i.e., layer II stellate cells and layer III pyramidal cells
[PCs]) is altered in Fmr1 KO mice. APs were evoked by a
ramp current injection (Yamada-Hanff and Bean, 2013) (Figure 1A). Only the first APs were used to determine AP threshold
to avoid the effect of ramp current cumulatively inactivating Na+
channels on the threshold of following APs (Figures 1A and 1B).
No changes in AP threshold was observed in the stellate cells of
Fmr1 KO mice (wild-type [WT]: 36.50 ± 0.56 mV, n = 7; KO:
36.65 ± 0.69 mV, n = 11; p = 0.517; Figure 1C). In contrast,
we found that the threshold potential of layer III PCs had a significant hyperpolarizing shift in Fmr1 KO mice (WT: 38.31 ±
3158 Cell Reports 16, 3157–3166, September 20, 2016

0.82 mV, n = 6; KO: 41.88 ± 0.33 mV,
n = 6; p = 0.0096; Figure 1C).
We further examined the excitability of
EC layer III PCs by setting the resting
membrane potential at 51 mV through
automatic current injection to induce AP
firing spontaneously. At this membrane
potential, about 70% of WT neurons and
all tested Fmr1 KO neurons fired spontaneously (data not shown).
Our results confirmed the increased excitability of these neurons
in Fmr1 KO mice, as evident by the increased mean firing frequency (WT: 3.75 ± 0.70 Hz, n = 23; KO: 6.12 ± 0.52 Hz, n = 48;
p = 0.0082; Figures 1D–1F) and decreased AP threshold (WT:
39.93 ± 0.33 mV; KO: 42.61 ± 0.21 mV; p < 0.00001; Figure 1G). We further verified the increased excitability of Fmr1
KO neurons by examining the distribution of instantaneous AP
firing frequency in the tested neurons (Figure 1E). Specifically,
we noted that, in Fmr1 KO neurons, the first peak of firing frequency shifted from 2.3 to 3.9 Hz, and an additional third peak appeared at 15 Hz (Figure 1E). Therefore, we used the layer III PCs
as a model to elucidate the underlying mechanisms of this defect.
Abnormal Persistent Na+ Current Causes Increased
Excitability in EC Layer III PCs of Fmr1 KO Mice
Because the intrinsic membrane properties play a major role
in setting neuronal excitability, we compared the resting
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Figure 2. Abnormal Persistent Na+ Current in EC Layer III PCs of
Fmr1 KO Mice
(A) Effect of Kv7 channel inhibitor XE991 on RMP (A1) and AP threshold (A2).
(B) Same as in (A), but for the HCN channel blocker ZD7288.
(C) Same as in (A), but for the INaP blocker, 20 nM TTX.
**p < 0.01; ns, not significant. All data are means ± SEM.

membrane potential (RMP), input resistance, and membrane
capacitance in EC layer III PCs of Fmr1 KO and WT animals,
but we found no significant differences in any of these parameters between genotypes (Figures S1A–S1C). Furthermore, we
found that changes in tonic excitatory/inhibitory inputs do not
account for the increased excitability of EC layer III PCs in
Fmr1 KO mice (Figure S2). In fact, we noted that spontaneous
inhibitory postsynaptic current (sIPSC) frequency was increased
in Fmr1 KO neurons (Figure S2B), suggesting a compensatory
action of tonic inhibition. However, this effect of tonic inhibition
was insufficient to counterbalance the increased excitability of
layer III PCs in Fmr1 KO mice, since our observations of
decreased AP threshold and increased firing in these neurons
were made in the intact EC circuits (Figures 1D–1G), in the presence of this compensatory effect of tonic inhibition.
Since sub-threshold currents are believed to have a critical
role in controlling RMP and regulating AP initiation and, thus,

setting neuronal excitability, we then probed whether changes
in sub-threshold currents play a role in the increased excitability
in Fmr1 KO neurons. There are three major types of subthreshold currents in central neurons: M current (IM, carried
by Kv7 channels), H current (Ih, carried by hyperpolarizationactivated cyclic nucleotide–gated (HCN) channels) and INaP
(Hönigsperger et al., 2015; Stafstrom, 2007; Yamada-Hanff
and Bean, 2013, 2015). Therefore, we used specific inhibitors
of IM, Ih, or INaP to probe their role in regulating neuronal excitability in EC layer III PCs. The Kv7 channel inhibitor XE991
(10 mM) had no detectable effect on RMP (Figure 2A1), suggesting a low activity of these channels at the potentials around RMP
in EC layer III PCs. XE991 slightly decreased the threshold
potential in both WT and Fmr1 KO neurons, but it failed to affect
the differences in threshold between genotypes (XE991: WT,
40.02 ± 0.71 mV, n = 7; KO, 44.01 ± 1.25 mV, n = 6;
p = 0.0051; Figure 2A2). Unlike XE991, the HCN channel blocker
ZD7288 (10 mM) markedly hyperpolarized the RMP, both in WT
and Fmr1 KO neurons to the same extent (ZD7288: WT,
79.20 ± 0.73, n = 6; KO, 79.83 ± 1.80 mV, n = 6; p = 0.769;
Figure 2B1), suggesting a high activity of HCN channels at the
potentials around RMP in both genotypes. However, ZD7288
failed to abolish the difference in AP threshold between genotypes (ZD7288: WT, 37.63 ± 0.97 mV; KO, 43.69 ± 0.66 mV;
p = 0.00047; Figure 2B2). Finally, low concentrations of tetrodotoxin (TTX) (20 nM) to block INaP (Hammarstrom and Gage, 1998)
had a small but significant hyperpolarizing effect on RMP in both
genotypes (basal: WT, 66.45 ± 0.78 mV, n = 11; KO, 66.12 ±
1.11 mV, n = 7; p = 0.816; TTX: WT, 70.0 ± 0.89 mV; KO,
68.57 ± 1.13 mV; p = 0.336; basal versus TTX within genotype:
WT, p = 0.0014; KO, p = 0.0023; Figure 2C1). Most importantly,
TTX (20 nM) abolished the difference in AP threshold between
genotypes (WT: 29.75 ± 0.87 mV; KO, 31.75 ± 1.48 mV;
p = 0.239; Figure 2C2). These results point to abnormal INaP,
but not IM or Ih, as a potential cause of the decreased AP
threshold in Fmr1 KO neurons.
Increased Persistent Sodium Current Underlies AP
Threshold Changes in Fmr1 KO Mice
To verify the aforementioned observations and examine changes
in INaP in Fmr1 KO neurons, we recorded INaP evoked by a slow
depolarization ramp (20 mV/s) to measure its quasi-steady-state
voltage dependence (Yamada-Hanff and Bean, 2015), using the
same internal and external solutions as those used in AP recordings (as described earlier). The TTX-sensitive current was first
evident at approximately 65 mV (Figure 3A). AP currents that
escaped voltage-clamp control were present in most neurons.
As expected, INaP was significantly increased in Fmr1 KO neurons (INaP at 40 mV: WT, 1.88 ± 0.55 pA/pF, n = 5; KO,
3.71 ± 0.52 pA/pF, n = 5; p = 0.0297; Figure 3B), while the
voltage-dependent activation of INaP was not altered in Fmr1
KO neurons (INaP half activation voltage, V1/2: WT, 41.1 ±
0.33 mV, n = 5; KO, 40.7 ± 0.19 mV, n = 5; p = 0.5638;
Figure 3C).
To further confirm these observations, we modified our protocol to avoid generation of escaped AP currents and achieve
more reliable INaP recordings. We also modified our recording
solutions to include blockers of K+ and Ca2+ channels to

Cell Reports 16, 3157–3166, September 20, 2016 3159

A

B1

B2

C1

C2

D1

D2

D3

E1

E2

E3

Figure 3. Enhanced Persistent Na+ Current Underlies AP Threshold Changes in Fmr1 KO Neurons
(A) INaP evoked by a depolarizing voltage ramp ( 100 to 20 mV, 20 mV/s) before (traces a) and during (traces b) the application of TTX. TTX-sensitive current
(traces c) was obtained by subtraction. Note that the large escaped AP currents were truncated to emphasize the INaP.
(B) I-V curves (B1) were constructed from the ramp-evoked INaP (mean current value over 0.01 mV intervals from averages of four to five trials for each cell to
approximate quasi-steady-state current). Currents were normalized to corresponding cell capacitance for better comparison. (B2) INaP at 40 mV was significantly larger in Fmr1 KO neurons.
(C) Voltage-dependent activation curve of INaP (C1). Data were fitted by Boltzmann function. Summarized data of half activation voltage, V1/2 (C2).

(legend continued on next page)
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minimize contamination of INaP measurements from Na+-activated K+ currents and other K+ and Ca2+ conductances. Briefly,
we used a Cs+-based internal solution supplemented with 4-AP
(2 mM) and TEA (10 mM) and also included TEA (20 mM, to
replace equimolar NaCl) and CdCl2 (100 mM) in external solution.
Under these conditions and using a repolarizing ramp voltage
(+30 to 65 mV, 50 mV/s) to evoked INaP, we could record
INaP without any AP currents out of voltage-clamp control. In
these measurements, we focused on the voltage in the range
from 65 to 20 mV for better comparison with the aforementioned results. It is noteworthy that, within a certain voltage
range, activation of INaP has been shown to be independent of
polarity of the voltage ramp (Astman et al., 2006). Indeed, consistent with the aforementioned findings, we found that INaP was
significantly larger in Fmr1 KO than WT neurons (INaP at
40mV: WT, 1.29 ± 0.23 pA/pF, n = 7; KO, 2.21 ±
0.32 pA/pF, n = 6; p = 0.0066; Figures 3D1 and 3D2). As in the
experiments described earlier, the voltage-dependent activation
of INaP was not different between genotypes (V1/2: WT, 36.27 ±
0.28 mV; KO, 36.49 ± 0.41 mV; p = 0.9738; Figure 3D3). We
note that V1/2 was shifted to a more depolarizing voltage in
both genotypes, compared to the aforementioned measurements (Figure 3C), presumably due to the changes in internal/
external solutions (Na+ and K+ gradients, K+ and Ca2+ channel
blockers). Finally, using a potent INaP inhibitor riluzole (10 mM)
(Spadoni et al., 2002; Urbani and Belluzzi, 2000), we further verified that the observed differences between Fmr1 KO and WT are
due to altered INaP. Indeed, riluzole (10 mM) eliminated differences in ramp-evoked current between genotypes (in riluzole
at 40 mV: WT, 0.83 ± 0.16 pA/pF, n = 6; KO, 1.06 ±
0.24 pA/pF, n = 6; p = 0.195; Figures 3E1 and 3E2). Together,
these results suggest that INaP is abnormally increased in Fmr1
KO neurons. Our measurements further indicate that, within
the voltage range used in our recordings, depolarizing and
repolarizing ramp measurements of INaP are largely equivalent.
Therefore, to avoid contamination from escaped AP currents,
in the following experiments, we use the repolarizing ramps to
record INaP.
If reduced AP threshold in Fmr1 KO neurons results from
increased INaP, then inhibition of INaP should abolish the differences in threshold between genotypes. Indeed, we found that riluzole (10 mM) abolished the difference in AP threshold between
genotypes (WT, 36.41 ± 2.15 mV, n = 6; KO, 37.38 ± 0.96,
n = 6; p = 0.710; Figure 3E3). Moreover, we also found that the
INaP opener veratridine (1 mM) shifted the threshold to a more
hyperpolarizing voltage in both genotypes, and, most importantly, it also abolished the difference in AP threshold between
genotypes (WT, 44.36 ± 0.98 mV, n = 6; KO, 44.98 ± 0.45,
n = 6; p = 0.613; Figure 3E3). The evidence that both INaP inhibitor
riluzole and INaP opener veratridine abolished the difference in
threshold between genotypes suggests that the abnormal INaP

is unlikely to be caused by altered expression of Na+ channels
in Fmr1 KO neurons. Taken together, these results suggest
that an abnormally enhanced INaP causes the increased excitability of EC layer III PCs in Fmr1 KO mice.
Hyperexcitability of EC Layer III PCs in Fmr1 KO Mice Is
Mediated by Exaggerated mGluR5 Signaling
Na+ channel activity is continuously and extensively modulated
by a variety of signaling pathways, including metabotropic
neurotransmitter receptors. Given a number of studies implicating dysfunction of mGluR5 or GABABR signaling pathways
in FXS models (Bear et al., 2004; Pacey et al., 2009; Wahlstrom-Helgren and Klyachko, 2015), both of which are known
to modulate Na+ channel properties (Crill, 1996), we examined
whether these signaling pathways play a role in the changes
of AP threshold in Fmr1 KO neurons. We first pharmacologically isolated the cells from glutamatergic and GABAergic
transmission networks by using a cocktail containing both
fast and slow synaptic transmission blockers (in micromolar:
50 APV, 10 DNQX, 5 gabazine, 2 CGP55845, and 10 MPEP to
block NMDA, AMPA, GABAA, GABAB, and mGluR5 receptors,
respectively). Surprisingly, the cocktail of these five blockers
completely abolished the difference in AP threshold between
genotypes (WT, 41.82 ± 0.15 mV, n = 6; KO, 42.01 ±
0.17 mV, n = 7; p = 0.462; Figure 4A), indicating that changes
in AP threshold in Fmr1 KO neurons are mediated by the activation of one or several signaling pathways coupled to these receptors. In line with our aforementioned findings that increased
excitability could not be attributed to network changes in fast
synaptic transmission, we found that inhibition of fast synaptic
transmission alone (with APV, DNQX, and gabazine) failed to
abolish the difference in threshold between genotypes (WT,
41.75 ± 0.48 mV, n = 12; KO, 43.71 ± 0.49 mV, n = 13;
p = 0.0079; Figure 4A), pointing to abnormal metabotropic
signaling pathways as mediators of AP threshold changes in
Fmr1 KO neurons. We further found that inhibition of GABAB receptors with CGP55845, in combination with fast transmission
blockers, shifted the threshold in a hyperpolarizing direction
for both genotypes, but more importantly, it failed to reduce differences in threshold between genotypes (WT, 43.10 ±
0.69 mV, n = 6; KO, 46.21 ± 0.61 mV, n = 6; p = 0.032;
Figure 4A). In contrast, the mGluR5 blocker MPEP in combination with the fast transmission blockers abolished differences in AP threshold between genotypes (WT, 41.43 ±
0.53 mV, n = 7; KO, 42.11 ± 0.50 mV, n = 6; p = 0.914; Figure 4A). These results single out the dysfunction of mGluR5
signaling as a mediator of AP threshold defect in EC layer III
PCs in Fmr1 KO mice. To verify this finding, we used another
specific mGluR5 antagonist fenobam. As expected, fenobam
(10 mM, in combination with fast transmission blockers and
CGP55845) abolished the difference in threshold between

(D) INaP evoked by a repolarizing ramp (D1; +30 to 65 mV, 50 mV/s). For better comparison with (A), the traces are presented in the same direction as in (A) in a
range from 65 to 20 mV. Arrow indicates the time direction. (D2) The difference of I-V curves between WT and Fmr1 KO neurons. Inset: INaP at 40 mV. (D3) The
voltage-dependent activation of INaP in Fmr1 KO and WT neurons. Inset: V1/2 of INaP activation.
(E) Effects of INaP inhibitor riluzole on INaP and the AP threshold in Fmr1 KO and WT neurons. (E1) Sample INaP traces. (E2) I-V curves. Inset: INaP at 40 mV.
(E3) Effects of the INaP inhibitor riluzole and INaP opener veratridine on the AP threshold.
*p < 0.05; **p < 0.01; ns, not significant. All data are means ± SEM.
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Figure 4. Exaggerated mGluR5-PLC-PKC Signaling Causes Enhanced Persistent Na+ Current in Fmr1 KO Neurons
(A) Effects of various combinations of blockers on AP threshold.
(B) Estimates for receptor contributions to cell excitability from (A).
(C) Sample INaP traces (upper panel) and summarized data (lower panel) for INaP measured in the presence of mGluR5 inhibitor MPEP in combination with four
other blockers (against NMDA, AMPA, GABAA, and GABAB receptors).
(D) Same as in (C) but for INaP measured with intracellular application of selective PLC inhibitor edelfosine.
(E) Same as in (C) but for INaP measured with intracellular application of PLC inhibitor U73122.
(F) Same as in (C) but for INaP measured with intracellular application of PKC inhibitor calphostin C.
(G) Same as in (C) but for INaP measured with intracellular application of PKC inhibitor PKC19–36.
(H) INaP values at 40 mV summarized from (C)–(G).
*p < 0.05; **p < 0.01; ns, not significant. All data are mean ± SEM.

3162 Cell Reports 16, 3157–3166, September 20, 2016

genotypes (WT, 41.94 ± 0.58 mV, n = 7; KO, 42.53 ±
0.26 mV, n = 8; p = 0.786; Figure 4A).
To further clarify this issue, we estimated the relative contributions of the aforementioned receptors to neuronal excitability
through comparison of the changes in AP threshold by their
specific blockers. In the WT neurons, the relative contribution
of combined activation of these five receptors to the AP
threshold is about +2 mV, as evident by subtracting threshold
values obtained with and without all five blockers (Figure 4B).
This can be interpreted to indicate that the network activity normally maintains the excitatory/inhibitory (E/I) balance via these
five receptors with slight inhibitory dominance. In contrast, in
Fmr1 KO neurons, the net effect of the same five receptors is
only about +0.06 mV, suggesting that the E/I balance in the
Fmr1 KO network shifts toward increased excitability. We note
that the addition of any blocker alters not only the individual
cells we recorded from but also the entire network excitability;
therefore, the contribution of a specific receptor to cell excitability can only be determined while all other receptors are
blocked. Thus, by subtracting threshold values obtained with
and without MPEP (or fenobam) in the presence of four other
blockers, this analysis demonstrates the markedly increased
contribution of mGluR5 signaling to AP threshold in Fmr1 KO
compared with WT neurons (MPEP: WT, 1.28 mV; KO,
4.20 mV; fenobam: WT, 1.16 mV; KO, 3.69 mV; Figure 4B).
In contrast, the contribution of GABABRs to the AP threshold
was very modest in both genotypes (Figure 4B). Taken together,
these results indicate that the decreased AP threshold in Fmr1
KO neurons is caused by the abnormally elevated mGluR5
signaling.
Exaggerated mGluR5 Signaling Acting via PLC-PKC
Pathway Causes Increased Persistent Na+ Current in
Fmr1 KO Neurons
Because our results demonstrate that enhanced INaP in Fmr1 KO
neurons decreases AP threshold, and that the abnormal AP
threshold is also attributed to the elevated mGluR5 activity, we
then asked whether the elevated mGluR5 signaling causes
enhanced INaP in Fmr1 KO neurons. To minimize the network influences from other glutamatergic or GABAergic receptors on
INaP, we measured INaP in the presence of four blockers of
NMDA, AMPA, GABAA, and GABAB receptors. First, we found
that INaP was still significantly larger in the Fmr1 KO than in the
WT neurons in the presence of these four blockers (INaP
at 40 mV: WT 1.40 ± 0.23 pA/pF, n = 7; KO, 2.33 ±
0.18 pA/pF, n = 7; p = 0.0092; Figures S3A and S3B) and was
nearly the same as INaP measured without the blockers (Figure 3D), while the voltage-dependent activation of INaP was unaffected in both genotypes (Figure S3C). These results support the
notion that these four receptors modulate AP threshold through
mechanisms other than INaP. In contrast, when mGluR5 blocker
MPEP (10 mM) was combined with the other four blockers, it
decreased the INaP in Fmr1 KO neurons (Figures 4C and 4H),
and, most importantly, MPEP abolished the difference in INaP
between genotypes (with MPEP, at 40 mV: WT, 1.20 ±
0.15 pA/pF, n = 6; KO, 1.14 ± 0.28 pA/pF, n = 6; p = 0.871; Figures 4C and 4H). We note that MPEP decreased INaP predominately in Fmr1 KO neurons, with negligible effect in WT neurons.

These results indicate that elevated mGluR5 signaling leads to
enhanced INaP in Fmr1 KO neurons.
Rapid normalization of INaP in Fmr1 KO neurons by acute inhibition of mGluR5 suggests that the effects of elevated mGluR5
signaling on INaP are mediated, at least in part, by the modulation
of Na+ channel activity. Indeed, pharmacological activation of
group I mGluRs has been shown to modulate the activity of
Na+ channels and, specifically, INaP (Carlier et al., 2006;
D’Ascenzo et al., 2009) in a PLC-dependent manner (D’Ascenzo
et al., 2009). To probe the signaling pathway mediating mGluR5
actions on INaP in Fmr1 KO neurons, we examined the effects of
disrupting the mGluR5-PLC signaling pathway using a selective
PLC inhibitor, edelfosine. Application of edelfosine (1 mM) via the
recording pipette (to avoid network effects) completely abolished the differences in INaP between genotypes (at 40 mV:
WT, 1.62 ± 0.20 pA/pF, n = 6; KO, 1.28 ± 0.21 pA/pF, n = 6;
p = 0.3089; Figures 4D and 4H). Intracellular application of
another PLC inhibitor U73122 (1 mM) similarly abolished the difference in INaP between genotypes (at 40 mV: WT, 1.10 ±
0.18 pA/pF, n = 6; KO, 1.27 ± 0.28 pA/pF, n = 6; p = 0.574; Figures 4E and 4H). PKC is the major downstream effector of PLC
activation (Mochly-Rosen et al., 2012) and is a well-known
modulator of Na+ channel activity (Li et al., 1993). Therefore,
we further tested whether PKC activation downstream of PLC
mediates the observed changes in INaP, using two potent and
selective PKC inhibitors, calphostin C and PKC19–36 (a pseudosubstrate peptide inhibitor of PKC). Intracellular application of
either calphostin C (10 mM) or PKC19–36 (2 mM) via the recording
pipette completely abolished the differences in INaP between genotypes (Figures 4F–4H) (calphostin C at 40 mV: WT, 1.16 ±
0.23 pA/pF, n = 6; KO, 1.42 ± 0.20 pA/pF, n = 6; p = 0.50199;
PKC19–36: WT, 1.18 ± 0.21 pA/pF, n = 7; KO, 1.11 ±
0.11 pA/pF, n = 6; p = 0.8308).
Taken together, our results suggest that an exaggerated activity of mGluR5 acting via the PLC-PKC signaling pathway enhances INaP in Fmr1 KO neurons, which, in turn, leads to
decreased AP threshold and increased neuronal excitability in
the EC layer III PCs of Fmr1 KO mice.
DISCUSSION
Here, we demonstrate that PCs in the EC layer III of Fmr1 KO
mice have a decreased AP threshold and increased excitability
caused by dysregulation of Na+ channels. Our results indicate
that this Na+ channel dysregulation is mediated by exaggerated
mGluR5-PLC-PKC signaling that markedly increases persistent
Na+ current in Fmr1 KO neurons. These findings suggest that
Na+ channel dysregulation plays a major role in neuronal hyperexcitability in an FXS mouse model. Our results also reveal an
important mechanism by which abnormal mGluR5 signaling
causes neuronal hyperexcitability in the absence of FMRP. The
finding that inhibition of INaP eliminates differences in the AP
threshold between Fmr1 KO and WT neurons suggests an
avenue for development of therapeutic strategies to normalize
neuronal hyperexcitability in FXS.
Emerging evidence links hyperexcitability in FXS with dysfunction in a number of ion channels, predominately K+ channels
(Brown et al., 2010; Deng et al., 2013; Gross et al., 2011;
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Kalmbach et al., 2015; Lee and Jan, 2012; Myrick et al., 2015;
Routh et al., 2013; Zhang et al., 2014) and HCN channels (Brager
et al., 2012; Zhang et al., 2014). Among the conductances that
modulate neuronal excitability, the sub-threshold voltage-dependent conductances are critical to both the membrane excitability
state and synaptic integration via regulation of both RMP and the
AP threshold. IM, Ih, and INaP are the three major sub-threshold
conductances in central neurons that are active and do not inactivate at sub-threshold voltages and, thus, play a critical role in
setting neuronal excitability (Hönigsperger et al., 2015; Yamada-Hanff and Bean, 2013, 2015). However, these three
conductances have distinct pattern of voltage dependence:
sub-threshold depolarization enhances IM and INaP but dampens
Ih; in contrast, sub-threshold hyperpolarization dampens IM and
INaP but enhances Ih. As a result, these three conductances differentially contribute to regulation of RMP and the AP threshold. In
agreement with this notion, we found that reduced AP threshold
of EC layer III PCs in Fmr1 KO mice is caused by enhanced INaP
but not IM or Ih. We note that our results do not exclude a possibility that, in addition to INaP, INaT is also altered in Fmr1 KO neurons.
Indeed, the maximal rise speed of AP, a Na+ channel-dependent
parameter, is increased in Fmr1 KO neurons (p = 0.00368; data
not shown), which might indicate a change in INaT.
Our data further indicate that changes in both INaP and the AP
threshold are mediated by exaggerated mGluR5 signaling in the
absence of FMRP. It is well accepted that loss of FMRP causes
abnormally elevated mGluR5 activity (Santoro et al., 2012). PLC
is a well-defined effector of mGluR5 signaling (Kettunen et al.,
2002) and is well known to modulate activity of voltage-gated
ion channels and, specifically, INaP (D’Ascenzo et al., 2009).
The receptor-dependent activation of PLC results in the generation of diacylglycerol and IP3. IP3, in turn, triggers the release of
calcium from the ER, causing a rise in cytosolic calcium concentration, which then activates PKC (Kettunen et al., 2002). Activation of PKC has been shown to increase neuronal excitability by
enhancing INaP at subthreshold voltages in neocortical neurons
(Astman et al., 2006). In addition, activation of mGluR5 by
DHPG in WT mice has been shown to upregulate INaP (Carlier
et al., 2006; D’Ascenzo et al., 2009). Our results suggest that
the increased INaP in Fmr1 KO neurons is caused by the exaggerated activity of mGluR5 acting via the PLC-PKC pathway. This is
a signaling mechanism distinct from the well-established signaling cascade by which abnormal mGluR5 activation impacts
local translation in Fmr1 KO animals (Santoro et al., 2012).
While we cannot rule out the possibility that changes in INaP
are mediated, in part, by altered Na+ channel expression, our
results indicate that the functional regulation of INaP by mGluR5
is sufficient to account for the changes in the AP threshold in
Fmr1 KO neurons. This notion is supported by the findings that
either INaP inhibitors or the INaP opener is sufficient to abolish
the differences in the AP threshold between genotypes. This is
further supported by the observation that, in PCs isolated from
circuit activity (via blockade of both ionic and metabotropic
transmission receptors), the maximal rise speed of AP is no
longer different between genotypes (p = 0.758; data not shown),
suggesting that, in the absence of circuit activity, Na+ channel
properties are similar in Fmr1 KO and WT animals. Taken
together, these results uncover a distinct mechanism by which
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abnormal mGluR5 signaling causes hyperexcitability in cortical
neurons of Fmr1 KO mice.
Effects of excessive mGluR5 signaling on circuit excitability
are reflected in the prolongation of persistent cortical activity,
or UP states, in Fmr1 KO mice (Hays et al., 2011), and our findings point to INaP as a potential target to alleviate these hyperexcitability defects. Indeed, although the amplitude of INaP is small,
relative to the transient Na+ current, this persistent component is
highly functionally significant because it is activated 10 mV
negative to the threshold potential and is characterized by steep
voltage dependence at subthreshold potentials, thus providing
strongly positive feedback for further depolarization (Bean,
2007; Crill, 1996). These features make neurons with increased
INaP particularly susceptible to hyperexcitability defects leading
to seizures (Stafstrom, 2007), a common dysfunction in FXS.
Indeed, pro-epileptic conditions have been associated with
€ller, 2000),
elevated INaP (Azouz et al., 1996; Somjen and Mu
and mutations in Na+ channels that cause increases in INaP
have been found in patients with epilepsy (Meisler and Kearney,
2005; Vreugdenhil et al., 2004; Rhodes et al., 2005). Moreover,
INaP inhibitors have been effective in treating both partial and
generalized tonic-clonic seizures in humans (Stafstrom, 2007).
A number of anti-epileptic drugs are INaP inhibitors and have no
effects on transient Na+ current at therapeutic concentrations
(Segal and Douglas, 1997; Spadoni et al., 2002; Taverna et al.,
1998). Given that hyperexcitability-associated phenotypes are
common in FXS, our finding that enhanced INaP has a profound
effect on neuronal excitability in EC layer III PCs of Fmr1 KO
mice suggests that it may play an important role in the pathophysiology of FXS. INaP may, thus, represent a therapeutic target
for treating hyperexcitability defects in FXS.
EXPERIMENTAL PROCEDURES
Animals and Slice Preparation
Fmr1 KO and WT control mice on FVB background were obtained from The
Jackson Laboratory. Slices were prepared as previously described (Deng
et al., 2013). All animal procedures were in compliance with the NIH Guide
for the Care and Use of Laboratory Animals and conformed to Washington University Animal Studies Committee guidelines.
Electrophysiology
Whole-cell recordings using a Multiclamp 700B amplifier (Molecular Devices)
were made from PCs or stellate cells of EC superficial layers. For INaP recordings, cell capacitance was compensated. Series resistance compensation
was enabled with 80%–90% correction and 16-ms lag. INaP was isolated by
subtracting current in 1 mM TTX from that before TTX. All recordings were conducted at near-physiological temperature (33 C–34 C).
Statistical Analysis
Data are presented as means ± SEM. Student’s paired or unpaired t test was
used for statistical analysis as appropriate; significance was set as p < 0.05.
The n was number of cells tested.
Additional details are available in the Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2016.08.046.
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